Dokter Biopsi tiroid terbaik di luar negeri — Halaman 3

Dr. Muhammed Mustafa Atci adalah Profesor Madya Onkologi Medis di Liv Hospital Topkapı. Beliau berspesialisasi dalam pengobatan kanker usus besar, payudara, lambung, dan paru-paru. Sebelumnya, beliau menjabat sebagai Koordinator Pendidikan di Rumah Sakit Kota Prof. Dr. Cemil Taşcıoğlu. Dr. Atci adalah anggota American Society of Clinical Oncology (ASCO).

• Penulis 19 makalah yang ditinjau sejawat tentang kanker gastrointestinal, toraks, dan endokrin.
• Menerbitkan studi tentang hasil kelangsungan hidup untuk kanker usus besar stadium IIB di Journal of Chemotherapy.
• Meneliti biomarker prognostik menggunakan pemindaian PET/CT dan volume tumor metabolik.
• Menangani kasus onkologi kompleks di klinik universitas İstinye University.

Dr. Irfan Cicin adalah Profesor Onkologi Medis di Rumah Sakit İstinye University Liv Topkapı. Beliau berspesialisasi dalam menangani kanker kompleks, termasuk glioblastoma, kanker paru-paru, dan tumor pankreas. Beliau menjabat sebagai profesor di Fakultas Kedokteran Universitas Trakya. Dr. Cicin sebelumnya pernah bertugas sebagai dokter di Angkatan Udara Turki.

• Melakukan terapi sistemik seperti imunoterapi, kemoterapi, dan terapi hormon.
• Menangani berbagai kondisi termasuk kasus ginekologi, ortopedi, dan neuro-onkologi.
• Pakar dalam HIPEC dan kemoembolisasi untuk keganasan hati dan perut.
• Bekerja di rumah sakit universitas dengan 300 tempat tidur dan 33 departemen medis.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dokter ini adalah ahli radiologi yang sangat serbaguna dengan keahlian luas di berbagai modalitas pencitraan diagnostik dan intervensi. Kemahiran klinis mencakup radiologi abdomen, Doppler, obstetri, payudara, muskuloskeletal, pediatrik, dan neuroradiologi, memastikan dukungan diagnostik yang komprehensif bagi beragam populasi pasien.

Selain pencitraan diagnostik, dokter ini terampil dalam melakukan prosedur intervensi non-vaskular, memberikan solusi invasif minimal untuk kondisi klinis yang kompleks. Pendekatan multidisiplin ini memungkinkan akurasi diagnostik yang tepat dan intervensi terapeutik yang efektif di berbagai spesialisasi medis.

Dokter ini adalah ahli bedah yang sangat terspesialisasi dengan keahlian luas dalam prosedur onkologi dan metabolik. Fokus klinisnya mencakup berbagai operasi kanker, termasuk intervensi kompleks untuk keganasan pankreas, saluran empedu, lambung, usus besar, dan tiroid, serta bedah payudara khusus.

Selain onkologi, dokter ini mahir dalam bedah bariatrik dan metabolik, menyediakan solusi bedah canggih untuk manajemen obesitas dan diabetes. Praktik ini berdedikasi untuk memberikan perawatan bedah yang komprehensif, menggunakan teknik berbasis bukti untuk menangani kondisi ganas maupun gangguan kesehatan metabolik.

Dr. Shady Mohammed El-sebai adalah Kepala Radiologi Intervensional di National Cancer Institute, Universitas Kairo. Beliau berspesialisasi dalam pencitraan onkologi dan prosedur invasif minimal. Dr. El-sebai menangani tumor hati, ginjal, dan jaringan lunak menggunakan teknik kemoembolisasi dan ablasi. Beliau bekerja di Rumah Sakit Onkologi Shef Al Orman, sebuah pusat yang terakreditasi ESMO.

• Melakukan ablasi gelombang mikro dan frekuensi radio untuk lesi tulang, paru-paru, dan tiroid.
• Pakar dalam biopsi yang dipandu USG dan CT, termasuk eksisi lesi payudara dengan Mammotome.
• Berspesialisasi dalam embolisasi arteri rahim untuk fibroid dan ablasi varises.
• Menangani kasus bilier dan ginjal yang kompleks dengan pemasangan stent perkutan dan drainase.

Dr. Jair Bar adalah ahli onkologi toraks dan Wakil Direktur Pusat Kanker di Sheba Medical Center. Beliau berspesialisasi dalam mengobati kanker paru-paru sel tidak kecil stadium lanjut menggunakan imunoterapi yang dipersonalisasi dan perawatan bertarget. Dr. Bar memegang gelar PhD dalam Biologi Molekuler dan memimpin laboratorium penelitian yang berfokus pada resistensi imunoterapi.

• Ketua Kelompok Kanker Paru-Paru Israel.
• Bersertifikat dalam Onkologi Medis dan Radioterapi Onkologi.
• Merawat pasien di Sheba Medical Center, salah satu dari 10 rumah sakit terbaik di dunia.
• Menggunakan profil molekuler dan genetik untuk membuat rencana perawatan kanker yang tepat.

Dr. Serkan Deveci adalah ahli urologi dan onko-bedah di Rumah Sakit Medical Park Göztepe, Istanbul. Beliau berspesialisasi dalam pengobatan kanker prostat, ginjal, dan testis. Dr. Deveci adalah seorang profesor dan anggota American Urological Association. Beliau telah menulis lebih dari 20 publikasi internasional mengenai kedokteran seksual dan uro-onkologi.

• Keahliannya mencakup nefrektomi dan prosedur biopsi khusus untuk berbagai kondisi.
• Editor bagian untuk UpToDate, sumber daya pendukung keputusan klinis yang digunakan di seluruh dunia.
• Anggota tim peninjau abstrak American Urological Association.
• Berpraktik di Medical Park Göztepe yang terakreditasi JCI, yang memiliki sertifikasi Pusat Bedah Robotik.

Dokter adalah seorang ginekolog yang berspesialisasi dalam operasi endoskopi dan laparoskopi. Dengan fokus pada teknik bedah yang minim invasif, dokter terampil dalam melakukan prosedur lanjutan yang meningkatkan pemulihan dan hasil pasien. Dokter memiliki pengalaman luas dalam menangani kasus ginekologi yang kompleks, memanfaatkan teknologi mutakhir untuk memberikan perawatan yang optimal.<\/p>

Profesor Moshe Papa mengepalai departemen bedah di Assuta Medical Center. Beliau membawa keahlian bedah senior untuk kasus-kasus yang memerlukan biopsi tiroid.

• Menjabat sebagai profesor di fakultas kedokteran Universitas Tel Aviv
• Mantan ahli bedah dan peneliti di National Institutes of Health di AS
• Memimpin prosedur bedah kompleks dan evaluasi diagnostik di Rumah Sakit Pusat Israel
• Mengoordinasikan perawatan dalam departemen bedah khusus untuk hasil yang akurat

Profesor Yoram Kluger adalah spesialis bedah onkologi di Rambam Medical Center. Beliau melakukan prosedur bedah dan memberikan evaluasi ahli bagi pasien yang memerlukan biopsi tiroid.

• Menjabat sebagai Profesor Bedah di universitas kedokteran terkemuka
• Berfokus pada onkologi bedah untuk menangani tumor ganas dan jinak
• Memberikan perawatan diagnostik tingkat tinggi bagi pasien dengan dugaan masalah tiroid

Dr. Karen Drumea adalah spesialis senior di Rambam Medical Center. Beliau berfokus pada onkologi dan radioterapi selama evaluasi biopsi tiroid.

• Pakar onkologi medis – menangani berbagai jenis kanker dengan terapi khusus
• Spesialis senior di Rambam Medical Center – rumah sakit pemerintah terkemuka di Israel
• Bersertifikat dalam radioterapi – menggunakan radiasi terarah untuk pengobatan kanker yang presisi

Dokter adalah seorang ahli bedah onkologi terkemuka dengan pengalaman luas dalam urologi. Mengkhususkan diri dalam teknik bedah canggih, dokter telah memberikan kontribusi signifikan di bidang onkologi urologi. Dengan fokus pada prosedur minimal invasif, dokter telah berhasil melakukan banyak operasi kompleks, meningkatkan hasil pasien. Dokter juga aktif terlibat dalam penelitian klinis, berkontribusi pada beberapa publikasi yang ditinjau sejawat dan mempresentasikan temuan di konferensi internasional.<\/p>

Dokter adalah seorang onkosurgeon dengan pengalaman 25 tahun, yang mengkhususkan diri dalam pengobatan kanker rektum dan kolon, bedah bariatrik, dan pengobatan kanker esofagus.<\/p>

Dengan lebih dari 15.000 prosedur bedah yang dilakukan, dokter melakukan lebih dari 1.000 operasi invasif minimal setiap tahun, menggunakan teknik laparoskopi dan robotik.<\/p>

Sebagai anggota masyarakat medis internasional, dokter adalah presiden Asosiasi Ahli Bedah-Endoskopis di Eropa dan memberikan kuliah tentang teknik bedah lanjutan dan laparoskopi.<\/p>

Dikenal sebagai pelopor dalam bedah gastrointestinal, dokter adalah yang pertama melakukan prosedur terobosan seperti pengangkatan kantong empedu melalui mulut dan eksisi mesorektal total transanal pertama (TaTME).<\/p>

Dokter adalah seorang gastroenterolog terkemuka yang berspesialisasi dalam penanganan kanker pankreas, saluran empedu, dan kandung empedu. Dengan pengalaman yang luas, dokter bertugas sebagai spesialis gastroenterologi di Departemen Gastroenterologi di Samsung Medical Center.<\/p>

Dokter menyelesaikan pendidikan kedokteran di Fakultas Kedokteran Universitas Hanyang di Korea Selatan, dengan pelatihan lebih lanjut di Sekolah Kedokteran Universitas Stanford di AS dan Rumah Sakit Palang Merah Kedua Kyoto di Jepang. Dokter juga merupakan anggota aktif dari The Korean Society of Gastrointestinal Endoscopy dan The Korean Society of Gastroenterology.<\/p>

Dokter adalah seorang onkoginekologis berprestasi dengan pengalaman luas dalam merawat kanker ginekologi. Mengkhususkan diri dalam teknik bedah lanjutan dan rencana perawatan yang dipersonalisasi, dokter telah berkontribusi secara signifikan dalam meningkatkan hasil pasien. Dengan banyak publikasi di jurnal yang ditinjau sejawat, dokter diakui atas keahliannya dalam prosedur minimal invasif dan telah menjadi pembicara utama di konferensi internasional.<\/p>

Dokter memiliki sertifikasi dewan dalam onkologi ginekologi dan terlibat aktif dalam penelitian klinis, berfokus pada terapi inovatif dan metode deteksi dini. Dokter berafiliasi dengan institusi medis terkemuka dan berkolaborasi dengan tim multidisiplin untuk memberikan perawatan komprehensif.<\/p>

Dokter adalah seorang onkosurgeon berprestasi dengan pengalaman luas dalam urologi. Sebagai Kepala Departemen Urologi Samsung, dokter telah memimpin berbagai prosedur bedah inovatif dan berkontribusi pada kemajuan signifikan di bidang ini. Dokter diakui atas keahliannya dalam teknik minimal invasif dan telah berperan penting dalam mengembangkan protokol baru untuk pengobatan kanker. Dokter sangat dihormati atas komitmennya terhadap perawatan pasien dan telah menerima banyak penghargaan atas kontribusinya dalam penelitian medis dan pendidikan.<\/p>

Dokter adalah seorang ginekolog yang sangat terampil dengan fokus khusus dalam onkoginekologi, memberikan perawatan ahli dalam diagnosis dan pengobatan kanker ginekologi. Dengan pengalaman luas dalam pendekatan bedah dan non-bedah, dokter berkomitmen untuk memajukan kesehatan wanita melalui perawatan inovatif dan perawatan penuh kasih.<\/p>

Dokter adalah seorang gastroenterolog terkemuka di Korea Selatan dan Asia, yang mengkhususkan diri dalam penanganan kanker pankreas, saluran empedu, dan kandung empedu, serta pankreatitis dan batu empedu.<\/p>

Saat ini berpraktik di Samsung Medical Center, dokter memiliki latar belakang pendidikan dari Fakultas Kedokteran Universitas Nasional Seoul dan Universitas California.<\/p>

Dokter adalah anggota aktif dari beberapa organisasi profesional, termasuk Masyarakat Endoskopi Gastrointestinal Korea, Masyarakat Gastroenterologi Korea, dan Asosiasi Pankreatobiliari Korea.<\/p>